DRY AGE-RELATED MACULAR DEGENERATION
Clinical trials for DRY AGE-RELATED MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new DRY AGE-RELATED MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for DRY AGE-RELATED MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a cord blood injection halt a leading cause of blindness?
Disease control Recruiting nowThis study is testing whether injections of a substance made from umbilical cord blood and platelets can slow or stop the progression of dry age-related macular degeneration (AMD), a common cause of vision loss in older adults. Researchers will give the injections to 36 participa…
Matched conditions: DRY AGE-RELATED MACULAR DEGENERATION
Phase: NA • Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Scientists test Lab-Grown eye cells to fight blinding disease
Disease control Recruiting nowThis early-stage study is testing whether transplanting lab-grown retinal cells into the eye is safe and tolerable for people with dry age-related macular degeneration (AMD). Researchers will enroll 18 adults over age 55 to receive cells derived from donor eye tissue. The main go…
Matched conditions: DRY AGE-RELATED MACULAR DEGENERATION
Phase: PHASE1, PHASE2 • Sponsor: Luxa Biotechnology, LLC • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Retinal implant trial offers hope for slowing vision loss in dry AMD
Disease control Recruiting nowThis study is testing whether a tiny implant placed under the retina can help preserve vision in people with advanced dry age-related macular degeneration (AMD). The trial will compare the implant against a simulated procedure in 24 participants with geographic atrophy, a severe …
Matched conditions: DRY AGE-RELATED MACULAR DEGENERATION
Phase: PHASE2 • Sponsor: Regenerative Patch Technologies, LLC • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Could cord blood injections halt vision loss in dry AMD?
Disease control Recruiting nowThis pilot study is testing whether injections of umbilical cord blood platelet-rich plasma into the eye can slow or stop the progression of dry age-related macular degeneration (AMD). Researchers will enroll 36 participants aged 65+ with bilateral dry AMD to compare the injectio…
Matched conditions: DRY AGE-RELATED MACULAR DEGENERATION
Phase: NA • Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Scientists test growing new eye cells from a Patient's own blood
Disease control Recruiting nowThis early-stage trial is testing the safety of a new procedure for advanced dry macular degeneration, a leading cause of vision loss. Researchers take a small blood sample from a patient, turn those cells into new retinal cells in a lab, and then transplant them back into the pa…
Matched conditions: DRY AGE-RELATED MACULAR DEGENERATION
Phase: PHASE1, PHASE2 • Sponsor: National Eye Institute (NEI) • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC